title: Temperature dependent photolabeling of the human angiotensin II type 1 receptor reveals insights into its conformational landscape and its activation mechanism.
abstract: We present a photoaffinity labeling study of the human Angiotensin II (AngII) type 1 receptor (hAT(1)) and a constitutively active mutant (CAM) N111G hAT(1) at multiple temperatures using a p-benzoyl-l-phenylalanine (Bpa) containing AngII analogue (125)I-[Sar(1), Bpa(8)] AngII and the Methionine Proximity Approach (MPA). By introducing Met residues, which react selectively with Bpa, by mutagenesis in hAT(1) and its CAM, we were able to identify the position of residues that surround the Bpa moiety in the receptor-ligand complexes. Here we refined this characterization by controlling and varying (from -20 to 50 degrees C) the temperature at which the photolabeling was carried out. The hAT(1) Met mutant, as well as CAM double mutant, photolabeled receptors were digested with CNBr and the fragmentation patterns were quantified by radioactive and densitometric analysis. Many important and significant changes in the fragmentation patterns were observed as function of both the temperature of photolysis and the context of constitutive activation. The ligand-receptor complex was increasingly flexible as temperature was increased, i.e. that the Bpa moiety could more easily label increasingly distant residues. These fragmentation patterns were converted into distance constraints that were included into a simulated annealing protocol in order to explore the extent of these conformational changes. In the context of constitutive activation, the 6th transmembrane domain (TM6) was found to exhibit a relative outward movement while TM2 and 5 were found to move closer to the ligand binding site. TM3 showed a slight displacement.
authors.affiliation: Département de Pharmacologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4.
authors.forename: Jason
authors.initials: J
authors.lastname: Arsenault
authors.forename: Jérôme
authors.initials: J
authors.lastname: Cabana
authors.forename: Dany
authors.initials: D
authors.lastname: Fillion
authors.forename: Richard
authors.initials: R
authors.lastname: Leduc
authors.forename: Gaétan
authors.initials: G
authors.lastname: Guillemette
authors.forename: Pierre
authors.initials: P
authors.lastname: Lavigne
authors.forename: Emanuel
authors.initials: E
authors.lastname: Escher
mesh_terms: D000804:Angiotensin II / Q000031:analogs & derivatives / Q000235:genetics / Q000378:metabolism; D001577:Benzophenones; D001665:Binding Sites / Q000235:genetics; D003488:Cyanogen Bromide / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008715:Methionine / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D008968:Molecular Conformation; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000235:genetics / Q000378:metabolism; D011485:Protein Binding / Q000235:genetics; D044140:Receptor, Angiotensin, Type 1 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D013696:Temperature
chemical_list: C488060:4-benzoylphenylalanine; D001577:Benzophenones; D008024:Ligands; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II; D010649:Phenylalanine; D008715:Methionine; D003488:Cyanogen Bromide